查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1684442

自動注射器市場，按類型、按疾病適應症、按最終用戶、按國家和地區 - 2025 年至 2032 年的行業分析、市場規模、市場佔有率和預測

Autoinjectors Market, By Type, By Disease Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年自動注射器市場規模價值為 11.0232 億美元，2025 年至 2032 年期間的複合年成長率為 13.90%。

自動注射器市場-市場動態

過敏反應、慢性疾病的日益普及以及藥物傳遞的進步預計將推動市場需求

全球自動注射器市場預計將顯著成長，這主要受多種因素的推動，包括慢性和緊急醫療狀況發病率的上升、藥物輸送系統的進步。糖尿病、類風濕性關節炎和多發性硬化症等慢性疾病需要定期注射藥物。自動注射器為患者提供了一種高效且使用者友好的自我用藥方式，提高了治療方案的依從性。嚴重的過敏反應通常由食物、昆蟲叮咬或藥物引起，需要立即使用腎上腺素治療。像 EpiPen 這樣的自動注射器被設計用於在過敏發作期間快速且準確地注射腎上腺素。人們對過敏反應及其可能危及生命的後果的認知不斷提高，推動了對腎上腺素自動注射器的需求。

此外，自動注射器設計的技術進步使得這些設備更加方便用戶使用、安全和有效。具有連接功能的智慧型自動注射器可以追蹤注射時間表，提高依從性。自動注射器消除了對經過訓練的藥物管理人員的需求。此外，FDA 和 EMA 等監管機構加快了對創新型自動注射器的核准，促進其進入市場。此外，許多國家優惠的報銷政策使患者更容易獲得這些設備，從而進一步提高了採用率。

自動注射器市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 13.90%

根據類型細分，預計一次性產品由於其易於使用和供應，將在 2024 年佔據最大的市場佔有率。

根據疾病適應症細分，糖尿病領域已成為 2024 年領先的疾病適應症領域，因為糖尿病患者護理對胰島素注射的需求不斷增加。

根據最終用戶細分，由於自我管理藥物的趨勢日益上升，家庭護理設定細分市場將成為 2024 年領先的最終用戶細分市場。

按地區分類，由於糖尿病盛行率高，北美將成為 2024 年的主要收入來源。類風濕性關節炎等

自動注射器市場-細分分析：

全球自動注射器市場根據類型、疾病指徵、最終用戶和地區進行細分。

根據類型，市場分為兩類：一次性和可重複使用。一次性產品佔據市場主導地位。便利性和提高治療方案依從性等好處正在促進這一細分市場的需求。

根據疾病指徵，市場分為五類：糖尿病、類風濕性關節炎、過敏反應、硬化症和其他。由於全球糖尿病盛行率高，預計糖尿病領域將佔據最大佔有率，而精準劑量的可用性正在推動市場成長。

根據最終用戶，市場分為三類：家庭護理環境、醫院和門診手術中心。家庭護理設定部分在最終用戶部分佔有最大的佔有率。先進的醫療保健的採用和自我藥療的更大便利預計將增加該領域的需求。

自動注射器市場-地理洞察

在全球範圍內，自動注射器市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。北美在全球自動注射器市場佔據主導地位。糖尿病、過敏性休克和類風濕性關節炎等慢性病的高發性，加上先進的醫療保健基礎設施和自我管理意識的增強，推動了市場的成長。由於慢性病發病率不斷上升，預計亞太地區將出現自動注射器市場的最高成長率。醫療保健意識的不斷提高、中國、印度和日本等國家的經濟成長以及政府為提高醫療保健的可及性和可負擔性而採取的舉措是推動市場發展的關鍵因素。

自動注射器市場-競爭格局：

自動注射器市場具有顯著的成長特徵，這得益於技術創新、主要參與者之間的策略合作以及人們對自我用藥的偏好日益成長。市場參與者提供廣泛的自我注射和輸液系統產品組合，例如，Ypsomed 專注於地理擴展和以患者為中心的產品。該公司推出了 YpsoMate 5.5，這是一個先進的自動注射器平台，專為容量範圍為 1.5 毫升至 5.5 毫升的液體藥物而設計。生物相似藥和生物製劑的批准增加擴大了可用於自動注射器輸送的藥物範圍，促進了市場成長。

最新動態：

2024年3月，Ypsomed開始向MTD集團出售胰島素筆針和血糖監測解決方案，以開發先進的智慧幫浦。

2023 年 10 月，Altaviz 推出了用於藥物輸送和生物製劑的 AltaVISC 自動注射器平台。

目錄

第 1 章：自動注射器市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 自動注射器市場片段（按類型）
    • 自動注射器市場片段（按疾病適應症）
    • 自動注射器市場片段（按最終用戶）
    • 自動注射器市場片段（按國家/地區）
    • 自動注射器市場片段（按地區）
  • 競爭洞察

第 3 章：自動注射器主要市場趨勢

  • 自動注射器市場促進因素
    • 市場促進因素的影響分析
  • 自動注射器市場限制
    • 市場限制的影響分析
  • 自動注射器市場機會
  • 自動注射器市場未來趨勢

第 4 章：自動注射器產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第5章：自動注射器市場：地緣政治緊張局勢升級的影響

  • 新冠肺炎疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第 6 章：自動注射器市場格局

  • 2024 年自動注射器市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：自動注射器市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 一次性的
    • 可重複使用的

第 8 章：自動注射器市場 - 按疾病適應症

  • 概述
    • 按疾病適應症分類的細分佔有率分析
    • 糖尿病
    • 類風濕關節炎
    • 過敏反應
    • 硬化
    • 其他

第 9 章：自動注射器市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 家庭護理設置
    • 醫院
    • 門診手術中心

第 10 章：自動注射器市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美自動注射器主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按類型）
    • 北美市場規模及預測（依疾病類型分類）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲自動注射器主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模及預測（依疾病類型分類）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區自動注射器主要製造商
    • 亞太地區市場規模及預測（依國家/地區分類）
    • 亞太地區市場規模及預測（按類型）
    • 亞太地區市場規模及預測（依疾病類型分類）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲自動注射器主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按類型）
    • 拉丁美洲市場規模及預測（依疾病類型分類）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 中東和非洲自動注射器主要製造商
    • MEA 市場規模及預測（依國家/地區分類）
    • MEA 市場規模和預測（按類型）
    • MEA 市場規模及預測（依疾病類型分類）
    • MEA 市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 11 章：主要供應商分析-自動注射器產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • SHL Medical AG
    • Ypsomed AG
    • Becton, Dickinson and Company
    • Eli Lilly and Company
    • Amgen Inc.
    • Altaviz
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • Pfizer Inc.
    • Antares Pharma, Inc.
    • Mylan NV
    • Gerresheimer AG
    • Owen Mumford Ltd.
    • Jabil Healthcare
    • Medeca Pharma AB
    • Credence MedSystems, Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4790

REPORT HIGHLIGHT

Autoinjectors Market size was valued at USD 1,102.32 Million in 2024, expanding at a CAGR of 13.90% from 2025 to 2032.

Autoinjectors are a kind of medical device designed to deliver a specific dose of medication, typically through an intramuscular or subcutaneous injection. They are often used for emergency or self-administration of drugs where quick and precise delivery is critical. These devices are preloaded with medication and feature a spring-loaded mechanism, making them easy to use, even for individuals without medical training.

Autoinjectors Market- Market Dynamics

Growing prevalence of anaphylaxis, chronic disorders and advancement in drug delivery are expected to propel market demand

The global autoinjectors market is expected to witness a significant growth, driven by a confluence of factors, including rising incidences of chronic and emergency medical conditions, advancements in drug delivery systems. Chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis require regular administration of injectable drugs. Autoinjectors provide an efficient and user-friendly way for patients to self-administer medication, improving adherence to treatment regimens. Severe allergic reactions, often triggered by food, insect stings, or medications, require immediate treatment with epinephrine. Autoinjectors like EpiPen are designed for rapid and accurate delivery of epinephrine during anaphylactic episodes. The increasing awareness of anaphylaxis and its potentially life-threatening consequences is driving the demand for epinephrine autoinjectors.

Further, technological advancements in autoinjector design have made these devices more user-friendly, safe, and effective. Smart autoinjectors with connectivity features allow tracking of injection schedules, enhancing compliance. Autoinjectors eliminate the need for trained personnel for drug administration. Moreover, regulatory bodies like the FDA and EMA have expedited approvals for innovative autoinjectors, facilitating their market entry. Additionally, favorable reimbursement policies in many countries make these devices more accessible to patients, further boosting adoption rates.

Autoinjectors Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.90% over the forecast period (2025-2032)

Based on Type segmentation, the disposable segment was predicted to show maximum market share in the year 2024, due to their ease of use & availability.

Based on Disease Indication segmentation, the diabetes segment was the leading Disease Indication segment in 2024, due to increasing need for insulin injections in diabetic patient care.

Based on End User segmentation, the homecare settings segment was the leading End User segment in 2024, due to the rising trend of self-administered medications.

On the basis of region, North America was the leading revenue generator in 2024, owing to high prevalence of diabetes. rheumatoid arthritis, etc.

Autoinjectors Market- Segmentation Analysis:

The Global Autoinjectors Market is segmented on the basis of Type, Disease Indication, End User, and Region.

The market is divided into two categories based on Type: disposable and reusable. The disposable segment dominates the market. Benefits such as convenience and improved compliance with treatment regimen are contributing to segment demand.

The market is divided into five categories based on the Disease Indication: diabetes, rheumatoid arthritis, anaphylaxis, sclerosis, and others. The diabetes segment is expected to hold the largest share due to the high prevalence of diabetes worldwide and availability of precise dosing is boosting market growth.

The market is divided into three categories based on End User: homecare settings, hospitals, and ambulatory surgical centers. The homecare settings segment holds the largest share in the End User segment. The adoption of advanced healthcare and greater convenience in self-medications are expected to increase segment demand.

Autoinjectors Market- Geographical Insights

Across the world, the Autoinjectors market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates in the global Autoinjectors market. The high prevalence of chronic conditions such as diabetes, anaphylaxis, and rheumatoid arthritis, coupled with advanced healthcare infrastructure and increased awareness about self-administration, propels market growth. The Asia Pacific region is anticipated to witness the highest growth rate in the autoinjectors market, driven by the increasing prevalence of chronic diseases. Rising healthcare awareness, economic growth in countries like China, India, and Japan, and government initiatives to enhance healthcare access and affordability are key factors propelling market development.

Autoinjectors Market- Competitive Landscape:

The autoinjectors market is characterized by significant growth, driven by technological innovations, strategic collaborations among key players, and an increasing preference for self-administration of medications. Market players offer an extensive portfolio of self-injection and infusion systems, for example, Ypsomed focuses on geographic expansion and patient-centric products. The company introduced the YpsoMate 5.5, an advanced autoinjector platform designed for liquid medications in the volume range of 1.5 ml to 5.5 ml. The increase in approvals for biosimilars and biologics expands the range of medications available for autoinjector delivery, contributing to market growth.

Recent Developments:

In March 2024, Ypsomed started selling insulin pen needle and blood sugar monitoring solutions to MTD Group to develop advanced smart pumps.

In October 2023, Altaviz launched the AltaVISC auto-injector platform for drug delivery & biologics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AUTOINJECTORS MARKET KEY PLAYERS

  • SHL Medical AG
  • Ypsomed AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Amgen Inc.
  • Altaviz
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Antares Pharma, Inc.
  • Mylan N.V.
  • Gerresheimer AG
  • Owen Mumford Ltd.
  • Jabil Healthcare
  • Medeca Pharma AB
  • Credence MedSystems, Inc.
  • Others

GLOBAL AUTOINJECTORS MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Disposable
  • Reusable

GLOBAL AUTOINJECTORS MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019-2032

  • Diabetes
  • Rheumatoid arthritis
  • Anaphylaxis
  • Sclerosis
  • Others

GLOBAL AUTOINJECTORS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Homecare settings
  • Hospitals
  • Ambulatory surgical centers

GLOBAL AUTOINJECTORS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Autoinjectors Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Autoinjectors Market Snippet by Type
    • 2.1.2. Autoinjectors Market Snippet by Disease Indication
    • 2.1.3. Autoinjectors Market Snippet by End User
    • 2.1.4. Autoinjectors Market Snippet by Country
    • 2.1.5. Autoinjectors Market Snippet by Region
  • 2.2. Competitive Insights

3. Autoinjectors Key Market Trends

  • 3.1. Autoinjectors Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Autoinjectors Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Autoinjectors Market Opportunities
  • 3.4. Autoinjectors Market Future Trends

4. Autoinjectors Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Autoinjectors Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Autoinjectors Market Landscape

  • 6.1. Autoinjectors Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Autoinjectors Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Disposable
    • 7.1.3. Reusable

8. Autoinjectors Market - By Disease Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Indication, 2024 & 2032 (%)
    • 8.1.2. Diabetes
    • 8.1.3. Rheumatoid arthritis
    • 8.1.4. Anaphylaxis
    • 8.1.5. Sclerosis
    • 8.1.6. Others

9. Autoinjectors Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Homecare settings
    • 9.1.3. Hospitals
    • 9.1.4. Ambulatory surgical centers

10. Autoinjectors Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Autoinjectors Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Autoinjectors Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Autoinjectors Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Autoinjectors Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Autoinjectors Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Autoinjectors Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. SHL Medical AG
    • 11.2.2. Ypsomed AG
    • 11.2.3. Becton, Dickinson and Company
    • 11.2.4. Eli Lilly and Company
    • 11.2.5. Amgen Inc.
    • 11.2.6. Altaviz
    • 11.2.7. Teva Pharmaceutical Industries Ltd.
    • 11.2.8. Novartis AG
    • 11.2.9. Pfizer Inc.
    • 11.2.10. Antares Pharma, Inc.
    • 11.2.11. Mylan N.V.
    • 11.2.12. Gerresheimer AG
    • 11.2.13. Owen Mumford Ltd.
    • 11.2.14. Jabil Healthcare
    • 11.2.15. Medeca Pharma AB
    • 11.2.16. Credence MedSystems, Inc.
    • 11.2.17. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us